Stay updated on Derazantinib in Advanced Cholangiocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page.

Latest updates to the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page
- Check6 days agoChange DetectedThe changes appear to be a UI/layout update to the study page, with no alterations to core content such as the study overview, eligibility criteria, outcomes, or locations. No data or study information appears to be modified.SummaryDifference0.1%

- Check13 days agoChange DetectedFooter revision updated from v3.4.1 to v3.4.2 and 'Bile duct cancer' was added as a related topic. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check20 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1.SummaryDifference0.1%

- Check27 days agoChange DetectedAdditions: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0. Deletions: Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4.SummaryDifference0.3%

- Check35 days agoChange DetectedThe screenshot updates are limited to minor UI/layout changes; all core study content, eligibility criteria, outcomes, and contact details appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.3.4 was added and v3.3.3 removed; these are minor version labels displayed on the page and do not affect content or functionality — To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Derazantinib in Advanced Cholangiocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page.